Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Total Debt (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Total Debt for 16 consecutive years, with $28.7 million as the latest value for Q3 2025.

  • Quarterly Total Debt fell 10.35% to $28.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $28.7 million through Sep 2025, down 10.35% year-over-year, with the annual reading at $34.2 million for FY2024, 56.77% up from the prior year.
  • Total Debt for Q3 2025 was $28.7 million at Xtant Medical Holdings, down from $34.3 million in the prior quarter.
  • The five-year high for Total Debt was $34.3 million in Q2 2025, with the low at $11.3 million in Q3 2022.
  • Average Total Debt over 5 years is $22.0 million, with a median of $18.4 million recorded in 2023.
  • The sharpest move saw Total Debt tumbled 80.95% in 2021, then surged 76.87% in 2024.
  • Over 5 years, Total Debt stood at $15.4 million in 2021, then decreased by 15.19% to $13.1 million in 2022, then skyrocketed by 66.76% to $21.8 million in 2023, then soared by 56.77% to $34.2 million in 2024, then dropped by 15.94% to $28.7 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $28.7 million, $34.3 million, and $33.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.